Burning Rock Biotech (BNR) Other Non-Current Liabilities (2021 - 2023)

Burning Rock Biotech has reported Other Non-Current Liabilities over the past 3 years, most recently at $630132.1 for Q4 2023.

  • Quarterly results put Other Non-Current Liabilities at $630132.1 for Q4 2023, up 8.67% from a year ago — trailing twelve months through Dec 2023 was $630132.1 (up 8.67% YoY), and the annual figure for FY2023 was $638000.0, up 3.87%.
  • Other Non-Current Liabilities for Q4 2023 was $630132.1 at Burning Rock Biotech, up from $579851.2 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for BNR hit a ceiling of $1.8 million in Q4 2021 and a floor of $579851.2 in Q4 2022.
  • Median Other Non-Current Liabilities over the past 3 years was $630132.1 (2023), compared with a mean of $1.0 million.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 68.52% in 2022 and later rose 8.67% in 2023.
  • Burning Rock Biotech's Other Non-Current Liabilities stood at $1.8 million in 2021, then crashed by 68.52% to $579851.2 in 2022, then grew by 8.67% to $630132.1 in 2023.
  • The last three reported values for Other Non-Current Liabilities were $630132.1 (Q4 2023), $579851.2 (Q4 2022), and $1.8 million (Q4 2021) per Business Quant data.